Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease

Newnham, D M; Dhillon, D P; Winter, J H; Jackson, C M; Clark, R A; Lipworth, B J
November 1993
Thorax;Nov1993, Vol. 48 Issue 11, p1151
Academic Journal
No abstract available.


Related Articles

  • New metered-dose inhaler for bronchospasm associated with COPD.  // Modern Medicine;Jan97, Vol. 65 Issue 1, p48 

    Reports on the US Food and Drug Administration's (FDA) approval of a combination of the anticholinergic bronchodilator ipratropium bromide and the beta2-adrenergic bronchodilator albuterol sulfate for patients with chronic obstructive pulmonary disease.

  • ipratropium bromide.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1230 

    A definition of the term "ipratropium bromide" which refers to an anticholinergic bronchodilator used for bronchoconstriction associated with chronic bronchitis, chronic obstructive pulmonary disease, emphysema, and asthma is presented.

  • Role of tiotropium in chronic obstructive pulmonary disease exacerbation. Pant, P.; Yadav, B.; Khan, G. M.; Koju, R.; Gurung, R.; Pokharel, B.; Bedi, T. R. S.; Adkhari, R. K. // Journal of Institute of Medicine;Aug2010, Vol. 32 Issue 2, p5 

    Introduction: Chronic obstructive pulmonary disease (COPD) remains a major public health problem. Many patients suffering from chronic obstructive lungs diseases are of poor economic status, mostly illiterate, therefore has a direct bearing on patient compliance. Tiotropium is a new...

  • Ipratropium lowers overall COPD treatment costs compared with albuterol.  // Formulary;Jun99, Vol. 34 Issue 6, p492 

    Discusses the advantages of using ipratropium over albuterol as the bronchodilator agent of choice for chronic obstructive pulmonary disease patients. Mechanism of action; Pharmacoeconomic analysis of ipratropium and albuterol; Number of patients surveyed.

  • Ipratropium bromide.  // Reactions Weekly;Jun2014, Vol. 1507 Issue 1, p20 

    An abstract of the article "Stress-induced cardiomyopathy associated with ipratropium bromide therapy in a patient with chronic obstructive pulmonary disease," by F. Melao and colleagues is presented.

  • Ipratropium bromide is more effective than Salmeterol - Fluticason combination on O2 saturation patients with COPD. Rezaie, Nader; Sadat Shams-Hosseini, Narges; Kashanizadeh, Atefeh; Karimi, Mohammad Ali // Journal of Research in Medical Sciences;Aug2013, Vol. 18 Issue 8, p731 

    A letter to the editor is presented on a study investigating the effectiveness of Ipratropium bromide and Salmeterol Fluticason (SFC) in chronic obstructive pulmonary disease (COPD) patients.

  • Out of breath. Snyder, Karyn // Drug Topics;6/26/95, Vol. 139 Issue 12, p44 

    Reports that retail pharmacists and home-health care providers are having difficulty in obtaining Atrovent Inhalation Solution or ipratropium bromide, an anticholinergic bronchodilator in nebulizer form manufactured by Boehringer Ingelheim. Use of the bronchodilator for treatment of chronic...

  • Combined Inhaled Bronchodilators in COPD. Miller, Karl E. // American Family Physician;8/15/2001, Vol. 64 Issue 4, p661 

    Presents information on a study by S. Benayoun and others on the impact of combined inhaled bronchodilators in the treatment of chronic obstructive pulmonary disease (COPD). Description of the study and its results; Conclusion that using the combined ipratropium and beta2 agonist metered-dose...

  • COPD inhaler raises cardiac risk. Praities, Nigel // Pulse;1/13/2010, Vol. 70 Issue 1, p13 

    The article discusses the findings of a research study about the impact of short-acting bronchodilator ipratropium for patients with chronic obstructive pulmonary disease (COPD), lead by professor Todd Lee at the Northwestern University in Chicago, Illinois.

  • ipratropium bromide.  // Taber's Cyclopedic Medical Dictionary;2005, p1139 

    A definition of the medical term "ipratropium bromide" is presented. It refers to an anticholinergic bronchodilator used for bronchoconstriction associated with chronic bronchitis, chronic obstructive pulmonary disease, asthma, and emphysema. The definition is from the "Taber's Cyclopedic...


Read the Article


Sign out of this library

Other Topics